Vertex Pharmaceuticals (VRTX) Goodwill & Intangibles (2009 - 2026)

Vertex Pharmaceuticals' Goodwill & Intangibles history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• On a quarterly basis, Goodwill & Intangibles fell 1.48% year-over-year to $1.5 billion in Q1 2026; TTM through Mar 2026 was $1.5 billion, a 1.48% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 20.99% from the prior year.
• Goodwill & Intangibles was little changed at $1.5 billion in Q1 2026 per VRTX's latest filing, from $1.5 billion in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $1.9 billion in Q4 2023 and bottomed at $1.4 billion in Q2 2022.
• The 5-year median for Goodwill & Intangibles is $1.7 billion (2022), against an average of $1.7 billion.
• Across the five-year window, Goodwill & Intangibles increased 21.77% in 2023 and dropped 20.99% in 2025, its largest moves.
• Year by year, Goodwill & Intangibles stood at $1.7 billion in 2022, then climbed by 14.68% to $1.9 billion in 2023, then dropped by 1.34% to $1.9 billion in 2024, then fell by 20.99% to $1.5 billion in 2025, then slipped by 0.38% to $1.5 billion in 2026.
• Per Business Quant, the three latest VRTX Goodwill & Intangibles figures stand at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025).